1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine has been researched along with agmatine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aguiar, AS; Castro, AA; Ferreira, J; Figueiredo, CP; Matheus, FC; Prediger, RD; Santos, AR; Tasca, CI; Villarinho, JG; Walz, R | 1 |
1 other study(ies) available for 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and agmatine
Article | Year |
---|---|
Neuroprotective effects of agmatine in mice infused with a single intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Administration, Intranasal; Agmatine; Analysis of Variance; Animals; Disease Models, Animal; Dopaminergic Neurons; Drug Administration Schedule; Drug Interactions; Exploratory Behavior; Female; Glutamic Acid; Hippocampus; Mice; Mice, Inbred C57BL; Motor Activity; Neurologic Examination; Neuroprotective Agents; Parkinsonian Disorders; Recognition, Psychology; Social Behavior; Substantia Nigra; Survival Analysis; Tritium; Tyrosine 3-Monooxygenase | 2012 |